59 related articles for article (PubMed ID: 15517324)
21. Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
Arias-Santiago S; Arrabal-Polo MA; Buendía-Eisman A; Arrabal-Martín M; Gutiérrez-Salmerón MT; Girón-Prieto MS; Jimenez-Pacheco A; Calonje JE; Naranjo-Sintes R; Zuluaga-Gomez A; Serrano Ortega S
J Am Acad Dermatol; 2012 Mar; 66(3):401-8. PubMed ID: 21835498
[TBL] [Abstract][Full Text] [Related]
22. Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer.
Kucerova R; Bienova M; Kral M; Bouchal J; Trtkova KS; Burdova A; Student V; Kolar Z
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):91-6. PubMed ID: 24665929
[TBL] [Abstract][Full Text] [Related]
23. [A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia].
Xu J; Qian WQ; Song JD
Zhonghua Nan Ke Xue; 2008 Jun; 14(6):533-7. PubMed ID: 18649754
[TBL] [Abstract][Full Text] [Related]
24. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study.
Arias-Santiago S; Gutiérrez-Salmerón MT; Castellote-Caballero L; Buendía-Eisman A; Naranjo-Sintes R
J Am Acad Dermatol; 2010 Sep; 63(3):420-9. PubMed ID: 20619491
[TBL] [Abstract][Full Text] [Related]
25. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract][Full Text] [Related]
26. Patients with a large prostate show a higher prevalence of androgenetic alopecia.
Chen W; Yang CC; Chen GY; Wu MC; Sheu HM; Tzai TS
Arch Dermatol Res; 2004 Nov; 296(6):245-9. PubMed ID: 15517324
[TBL] [Abstract][Full Text] [Related]
27. Androgenetic alopecia.
Otberg N; Finner AM; Shapiro J
Endocrinol Metab Clin North Am; 2007 Jun; 36(2):379-98. PubMed ID: 17543725
[TBL] [Abstract][Full Text] [Related]
28. [Androgenetic alopecia].
Jamin C
Ann Dermatol Venereol; 2002 May; 129(5 Pt 2):801-3. PubMed ID: 12223962
[TBL] [Abstract][Full Text] [Related]
29. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in relation to the patient's risk profile for progression.
Trachtenberg J
BJU Int; 2005 Jun; 95 Suppl 4():6-11. PubMed ID: 15871730
[TBL] [Abstract][Full Text] [Related]
30. Hair loss in women.
Camacho-Martínez FM
Semin Cutan Med Surg; 2009 Mar; 28(1):19-32. PubMed ID: 19341939
[TBL] [Abstract][Full Text] [Related]
31. Definition of at-risk patients: dynamic variables.
Emberton M
BJU Int; 2006 Apr; 97 Suppl 2():12-5; discussion 21-2. PubMed ID: 16507047
[TBL] [Abstract][Full Text] [Related]
32. Drug Insight: 5alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia.
Marberger M
Nat Clin Pract Urol; 2006 Sep; 3(9):495-503. PubMed ID: 16964191
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla.
Inui S; Itami S
J Dermatol Sci; 2011 Jan; 61(1):1-6. PubMed ID: 21167691
[TBL] [Abstract][Full Text] [Related]
34. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
Naslund MJ; Miner M
Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
[TBL] [Abstract][Full Text] [Related]
35. Benign prostatic hyperplasia: a review of its histogenesis and natural history.
Oesterling JE
Prostate Suppl; 1996; 6():67-73. PubMed ID: 8630233
[TBL] [Abstract][Full Text] [Related]
36. Current understanding of androgenetic alopecia. Part II: clinical aspects and treatment.
Hoffmann R; Happle R
Eur J Dermatol; 2000; 10(5):410-7. PubMed ID: 10882953
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
